AI-generated summary
The authors pooled seven studies of 691 children to compare repeated low-level red-light therapy with orthokeratology and atropine for slowing myopia. They report that red-light therapy was associated with less axial length growth and greater choroidal thickening, with no serious adverse events reported. The authors note that further well-designed trials with longer follow-up are needed to confirm clinical value.
- Participants
- 691
- Studies included
- 7
- Who or what was studied
- Children with myopia (pediatric participants)
- Limits stated in the abstract
- The authors report high heterogeneity (I2 = 93.5%) and call for further well-designed trials with longer follow-ups.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Meta-analysis, Systematic review, Control group, Myopia, Randomized controlled trial, Publication bias, Heterogeneity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.